Global Human Microbiome Therapeutics Market 2018 - Industry Research Report

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE
 

Global Human Microbiome Therapeutics Market 2018 - Industry Research Report

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 90   |    Publisher : Extense Research

This report focuses on the global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Microbiome Therapeutics development in United States, Europe and China.

Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.
One of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals.
The latest trend gaining momentum in the market is growing investments from venture capitalists. Venture capitalists are capitalizing on the need for effective treatment and are offering therapeutic treatment solutions to treat disorders such as autoimmune disorders, infections, and cancer. 
In 2017, the global Human Microbiome Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Enterome Bioscience
    Rebiotix
    Seres Therapeutics
    Vedanta Biosciences
    Bristol-Myers Squibb
    Johnson & Johnson
    Takeda Pharmaceutical
    ...

Market segment by Type, the product can be split into
    FMT
    Microbiome Drugs

Market segment by Application, split into
    C. difficile
    Crohn’s Disease
    Inflammatory Bowel Disease
    Diabetes
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Human Microbiome Therapeutics development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Microbiome Therapeutics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type (2013-2025)
        1.4.2 FMT
        1.4.3 Microbiome Drugs
    1.5 Market by Application
        1.5.1 Global Human Microbiome Therapeutics Market Share by Application (2013-2025)
        1.5.2 C. difficile
        1.5.3 Crohn’s Disease
        1.5.4 Inflammatory Bowel Disease
        1.5.5 Diabetes
        1.5.6 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Human Microbiome Therapeutics Market Size
    2.2 Human Microbiome Therapeutics Growth Trends by Regions
        2.2.1 Human Microbiome Therapeutics Market Size by Regions (2013-2025)
        2.2.2 Human Microbiome Therapeutics Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Human Microbiome Therapeutics Market Size by Manufacturers
        3.1.1 Global Human Microbiome Therapeutics Revenue by Manufacturers (2013-2018)
        3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
    3.2 Human Microbiome Therapeutics Key Players Head office and Area Served
    3.3 Key Players Human Microbiome Therapeutics Product/Solution/Service
    3.4 Date of Enter into Human Microbiome Therapeutics Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Human Microbiome Therapeutics Market Size by Type (2013-2018)
    4.2 Global Human Microbiome Therapeutics Market Size by Application (2013-2018)

5 United States
    5.1 United States Human Microbiome Therapeutics Market Size (2013-2018)
    5.2 Human Microbiome Therapeutics Key Players in United States
    5.3 United States Human Microbiome Therapeutics Market Size by Type
    5.4 United States Human Microbiome Therapeutics Market Size by Application

6 Europe
    6.1 Europe Human Microbiome Therapeutics Market Size (2013-2018)
    6.2 Human Microbiome Therapeutics Key Players in Europe
    6.3 Europe Human Microbiome Therapeutics Market Size by Type
    6.4 Europe Human Microbiome Therapeutics Market Size by Application

7 China
    7.1 China Human Microbiome Therapeutics Market Size (2013-2018)
    7.2 Human Microbiome Therapeutics Key Players in China
    7.3 China Human Microbiome Therapeutics Market Size by Type
    7.4 China Human Microbiome Therapeutics Market Size by Application

8 Japan
    8.1 Japan Human Microbiome Therapeutics Market Size (2013-2018)
    8.2 Human Microbiome Therapeutics Key Players in Japan
    8.3 Japan Human Microbiome Therapeutics Market Size by Type
    8.4 Japan Human Microbiome Therapeutics Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Human Microbiome Therapeutics Market Size (2013-2018)
    9.2 Human Microbiome Therapeutics Key Players in Southeast Asia
    9.3 Southeast Asia Human Microbiome Therapeutics Market Size by Type
    9.4 Southeast Asia Human Microbiome Therapeutics Market Size by Application

10 India
    10.1 India Human Microbiome Therapeutics Market Size (2013-2018)
    10.2 Human Microbiome Therapeutics Key Players in India
    10.3 India Human Microbiome Therapeutics Market Size by Type
    10.4 India Human Microbiome Therapeutics Market Size by Application

11 Central & South America
    11.1 Central & South America Human Microbiome Therapeutics Market Size (2013-2018)
    11.2 Human Microbiome Therapeutics Key Players in Central & South America
    11.3 Central & South America Human Microbiome Therapeutics Market Size by Type
    11.4 Central & South America Human Microbiome Therapeutics Market Size by Application

12 International Players Profiles
    12.1 Enterome Bioscience
        12.1.1 Enterome Bioscience Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Human Microbiome Therapeutics Introduction
        12.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.1.5 Enterome Bioscience Recent Development
    12.2 Rebiotix
        12.2.1 Rebiotix Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Human Microbiome Therapeutics Introduction
        12.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.2.5 Rebiotix Recent Development
    12.3 Seres Therapeutics
        12.3.1 Seres Therapeutics Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Human Microbiome Therapeutics Introduction
        12.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.3.5 Seres Therapeutics Recent Development
    12.4 Vedanta Biosciences
        12.4.1 Vedanta Biosciences Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Human Microbiome Therapeutics Introduction
        12.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.4.5 Vedanta Biosciences Recent Development
    12.5 Bristol-Myers Squibb
        12.5.1 Bristol-Myers Squibb Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Human Microbiome Therapeutics Introduction
        12.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.5.5 Bristol-Myers Squibb Recent Development
    12.6 Johnson & Johnson
        12.6.1 Johnson & Johnson Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Human Microbiome Therapeutics Introduction
        12.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.6.5 Johnson & Johnson Recent Development
    12.7 Takeda Pharmaceutical
        12.7.1 Takeda Pharmaceutical Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Human Microbiome Therapeutics Introduction
        12.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2013-2018)
        12.7.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Human Microbiome Therapeutics Key Market Segments
    Table Key Players Human Microbiome Therapeutics Covered
    Table Global Human Microbiome Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Human Microbiome Therapeutics Market Size Market Share by Type 2013-2025
    Figure FMT Figures
    Table Key Players of FMT
    Figure Microbiome Drugs Figures
    Table Key Players of Microbiome Drugs
    Table Global Human Microbiome Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
    Figure C. difficile Case Studies
    Figure Crohn’s Disease Case Studies
    Figure Inflammatory Bowel Disease Case Studies
    Figure Diabetes Case Studies
    Figure Others Case Studies
    Figure Human Microbiome Therapeutics Report Years Considered
    Table Global Human Microbiome Therapeutics Market Size 2013-2025 (Million US$)
    Figure Global Human Microbiome Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Human Microbiome Therapeutics Market Size by Regions 2013-2025 (Million US$)
    Table Global Human Microbiome Therapeutics Market Size by Regions 2013-2018 (Million US$)
    Table Global Human Microbiome Therapeutics Market Share by Regions 2013-2018
    Figure Global Human Microbiome Therapeutics Market Share by Regions 2013-2018
    Figure Global Human Microbiome Therapeutics Market Share by Regions 2018
    Table Market Top Trends
    Table Global Human Microbiome Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Human Microbiome Therapeutics Market Share by Manufacturers (2013-2018)
    Figure Global Human Microbiome Therapeutics Market Share by Manufacturers in 2018
    Table Global Human Microbiome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Human Microbiome Therapeutics Product/Solution/Service
    Table Date of Enter into Human Microbiome Therapeutics Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Global Human Microbiome Therapeutics Market Size Share by Type (2013-2018)
    Figure Global Human Microbiome Therapeutics Market Size Market Share by Type (2013-2018)
    Table Global Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Global Human Microbiome Therapeutics Market Size Share by Application (2013-2018)
    Figure Global Human Microbiome Therapeutics Market Size Market Share by Application (2013-2018)
    Figure Global Human Microbiome Therapeutics Revenue Market Share by Application in 2017
    Figure United States Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table United States Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table United States Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table United States Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table United States Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table United States Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table United States Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Figure Europe Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table Europe Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table Europe Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table Europe Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Europe Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table Europe Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Europe Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Figure China Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table China Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table China Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table China Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table China Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table China Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table China Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Figure Japan Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table Japan Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table Japan Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table Japan Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Japan Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table Japan Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Japan Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Figure Southeast Asia Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table Southeast Asia Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table Southeast Asia Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Figure India Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table India Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table India Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table India Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table India Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table India Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table India Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Figure Central & South America Human Microbiome Therapeutics Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Human Microbiome Therapeutics Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Human Microbiome Therapeutics Market Share (2017-2018)
    Table Central & South America Human Microbiome Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Human Microbiome Therapeutics Market Share by Type (2013-2018)
    Table Central & South America Human Microbiome Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Human Microbiome Therapeutics Market Share by Application (2013-2018)
    Table Enterome Bioscience Company Details
    Table Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2013-2018) (Million US$)
    Figure Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Enterome Bioscience Recent Development
    Table Rebiotix Company Details
    Table Rebiotix Revenue in Human Microbiome Therapeutics Business (2013-2018)(Million US$)
    Figure Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Rebiotix Recent Development
    Table Seres Therapeutics Company Details
    Table Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2013-2018)(Million US$)
    Figure Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Seres Therapeutics Recent Development
    Table Vedanta Biosciences Company Details
    Table Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2013-2018)(Million US$)
    Figure Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Vedanta Biosciences Recent Development
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2013-2018)(Million US$)
    Figure Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Bristol-Myers Squibb Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2013-2018)(Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Johnson & Johnson Recent Development
    Table Takeda Pharmaceutical Company Details
    Table Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2013-2018)(Million US$)
    Figure Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2013-2018)
    Table Takeda Pharmaceutical Recent Development
    Table Global Human Microbiome Therapeutics Market Size by Regions (Million US$) 2018-2025
    Figure Global Human Microbiome Therapeutics Market Size Share by Regions (2018-2025)
    Figure Global Human Microbiome Therapeutics Market Size Share by Regions in 2025
    Figure United States Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure China Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure India Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Human Microbiome Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Table Global Human Microbiome Therapeutics Market Size by Product (2018-2025) (Million US$)
    Figure Global Human Microbiome Therapeutics Market Size by Product (2018-2025)
    Figure Global Human Microbiome Therapeutics Market Size by Product in 2025
    Table Global Human Microbiome Therapeutics Market Size by Application (2018-2025) (Million US$)
    Figure Global Human Microbiome Therapeutics Market Size by Application (2018-2025)
    Figure Global Human Microbiome Therapeutics Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@extentresearch.com